← Back to all trials
Active Not Recruiting
NCT05508763
Personalised Therapeutics @LUMC
Conditions: Adverse Drug Reaction
Sex: All
Ages: 18 Years – N/A
Enrollment: 2000
Sponsor: Leiden University Medical Center
Location: Leiden University Medical Center Leiden South Holland
Summary
In PT@LUMC 2000 patients will be randomized between a PGx-guided dosing group and a standard of care group. The patients will be followed for one year in which they will be asked to report adverse drug reactions at one, three, six and twelve months.
Eligibility Criteria
Inclusion Criteria:
* Provision of informed consent (IC) prior to any study specific procedures.
* Be aged ≥18
* A venapunction as part of routine treatment
* Receive a medication verification interview
* Be able and willing to be followed-up for at least one year
Exclusion Criteria:
* Pregnancy or lactating
* Previous participation in the PREPARE trial (NCT03093818, NL60069.058.16)
Source: ClinicalTrials.gov (NCT05508763). StuddyBuddy aggregates publicly available trial information.
